Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients

Thromb Haemost. 2021 Jan;121(1):98-101. doi: 10.1055/s-0040-1721317. Epub 2020 Nov 19.

Authors

Luca Valerio¹, Paola Ferrazzi², Clara Sacco², Wolfram Ruf¹, Nils Kucher³, Stavros V Konstantinides^{1

4}, Stefano Barco^{1

3}, Corrado Lodigiani²; Humanitas COVID-19 Task Force

Affiliations

¹ Center for Thrombosis and Hemostasis, University Medical Center, University of Mainz, Mainz, Germany.
² Center for Thrombosis and Hemorrhagic Diseases, Humanitas Clinical and Research Center-IRCCS, Rozzano, Milan, Italy.
³ Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.
⁴ Department of Cardiology, Democritus University of Thrace, Alexandroupolis, Greece.

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Aged
Aged, 80 and over
Biomarkers / blood
C-Reactive Protein / metabolism*
COVID-19 / blood*
COVID-19 / diagnosis
COVID-19 / mortality
Female
Fibrin Fibrinogen Degradation Products / metabolism*
Hospitalization
Humans
Male
Middle Aged
Prognosis
Retrospective Studies
Time Factors

Substances

Biomarkers
Fibrin Fibrinogen Degradation Products
fibrin fragment D
C-Reactive Protein